Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChinaTech Peptide is a China-based peptide development and manufacturing company focused on custom and generic peptides. The company appears to operate primarily as a peptide CDMO/CMO rather than as a therapeutic drug developer, offering synthesis services from milligram to kilogram scale and supporting laboratory, pilot-plant, and GMP-level manufacturing. Its products and services include custom peptide synthesis, peptide APIs and intermediates, cosmetic peptides, and generic peptides for pharmaceutical, agricultural, and veterinary applications. Available public information indicates operations in Suzhou, Jiangsu, China and longstanding collaboration with research organizations, universities, and pharmaceutical companies. The company does not appear to have a clearly disclosed proprietary clinical pipeline in readily accessible public sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChinaTech Peptide.